Veeva Systems Inc. (0LO3.L)
USD 217.0
(-1.92%)
USD 217.0
(-1.92%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | 429.33 Million USD | -6.48% |
| 2023 | 459.09 Million USD | -9.18% |
| 2022 | 505.49 Million USD | 33.8% |
| 2021 | 377.79 Million USD | 31.99% |
| 2020 | 286.21 Million USD | 28.43% |
| 2019 | 222.86 Million USD | 47.8% |
| 2018 | 150.79 Million USD | 39.66% |
| 2017 | 107.96 Million USD | 37.38% |
| 2016 | 78.58 Million USD | 12.32% |
| 2015 | 69.96 Million USD | 78.01% |
| 2014 | 39.3 Million USD | 30.87% |
| 2013 | 30.03 Million USD | 352.44% |
| 2012 | 6.63 Million USD | 30.39% |
| 2011 | 5.09 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q4 | 135.26 Million USD | 5.27% |
| 2024 Q1 | 61.53 Million USD | -43.51% |
| 2024 Q2 | 104.04 Million USD | 69.1% |
| 2024 FY | 429.33 Million USD | -6.48% |
| 2024 Q3 | 128.48 Million USD | 23.49% |
| 2023 Q3 | 121.4 Million USD | 20.09% |
| 2023 Q1 | 127.67 Million USD | 6.64% |
| 2023 FY | 459.09 Million USD | -9.18% |
| 2023 Q2 | 101.09 Million USD | -20.82% |
| 2023 Q4 | 108.92 Million USD | -10.28% |
| 2022 Q4 | 119.71 Million USD | -9.79% |
| 2022 Q2 | 124.62 Million USD | -2.98% |
| 2022 Q1 | 128.44 Million USD | 29.95% |
| 2022 FY | 505.49 Million USD | 33.8% |
| 2022 Q3 | 132.7 Million USD | 6.49% |
| 2021 Q4 | 98.84 Million USD | -2.43% |
| 2021 FY | 377.79 Million USD | 31.99% |
| 2021 Q1 | 87.56 Million USD | 44.99% |
| 2021 Q3 | 101.3 Million USD | 12.46% |
| 2021 Q2 | 90.08 Million USD | 2.87% |
| 2020 Q1 | 71.16 Million USD | 12.97% |
| 2020 Q3 | 80.8 Million USD | 9.4% |
| 2020 FY | 286.21 Million USD | 28.43% |
| 2020 Q4 | 60.39 Million USD | -25.25% |
| 2020 Q2 | 73.85 Million USD | 3.78% |
| 2019 FY | 222.86 Million USD | 47.8% |
| 2019 Q4 | 62.99 Million USD | -0.15% |
| 2019 Q3 | 63.09 Million USD | 19.46% |
| 2019 Q2 | 52.81 Million USD | 20.16% |
| 2019 Q1 | 43.95 Million USD | 26.0% |
| 2018 FY | 150.79 Million USD | 39.66% |
| 2018 Q3 | 41.66 Million USD | 12.93% |
| 2018 Q4 | 34.88 Million USD | -16.27% |
| 2018 Q1 | 37.33 Million USD | 14.78% |
| 2018 Q2 | 36.89 Million USD | -1.18% |
| 2017 Q1 | 17.8 Million USD | 17.06% |
| 2017 Q4 | 32.53 Million USD | -3.79% |
| 2017 FY | 107.96 Million USD | 37.38% |
| 2017 Q3 | 33.81 Million USD | 41.93% |
| 2017 Q2 | 23.82 Million USD | 33.79% |
| 2016 Q2 | 22.35 Million USD | 6.82% |
| 2016 Q1 | 20.92 Million USD | 1.17% |
| 2016 FY | 78.58 Million USD | 12.32% |
| 2016 Q4 | 15.21 Million USD | -24.32% |
| 2016 Q3 | 20.1 Million USD | -10.08% |
| 2015 FY | 69.96 Million USD | 78.01% |
| 2015 Q4 | 20.68 Million USD | 3.72% |
| 2015 Q3 | 19.94 Million USD | 18.8% |
| 2015 Q2 | 16.78 Million USD | 33.67% |
| 2015 Q1 | 12.55 Million USD | 11.05% |
| 2014 Q2 | 9.83 Million USD | 20.37% |
| 2014 FY | 39.3 Million USD | 30.87% |
| 2014 Q3 | 9.98 Million USD | 1.49% |
| 2014 Q4 | 11.3 Million USD | 13.25% |
| 2014 Q1 | 8.17 Million USD | -12.7% |
| 2013 Q4 | 9.36 Million USD | 6.58% |
| 2013 Q3 | 8.78 Million USD | 0.0% |
| 2013 FY | 30.03 Million USD | 352.44% |
| 2012 FY | 6.63 Million USD | 30.39% |
| 2011 FY | 5.09 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Phreesia, Inc. | -131.77 Million USD | 425.813% |
| Accuray Incorporated | 504 Thousand USD | -85085.317% |
| Align Technology, Inc. | 643.33 Million USD | 33.265% |
| Elevance Health Inc. | 133.96 Billion USD | 99.68% |
| AxoGen, Inc. | -21.46 Million USD | 2100.438% |
| Boston Scientific Corporation | 2.34 Billion USD | 81.676% |
| CVS Health Corporation | 13.74 Billion USD | 96.876% |
| Cardinal Health, Inc. | 1.24 Billion USD | 65.46% |
| Centene Corporation | 2.93 Billion USD | 85.347% |
| DaVita Inc. | 1.6 Billion USD | 73.213% |
| HCA Healthcare, Inc. | 9.62 Billion USD | 95.54% |
| Hologic, Inc. | 970.2 Million USD | 55.748% |
| Humana Inc. | 4.01 Billion USD | 89.301% |
| IDEXX Laboratories, Inc. | 1.09 Billion USD | 60.867% |
| Laboratory Corporation of America Holdings | 725.6 Million USD | 40.83% |
| Masimo Corporation | 136.5 Million USD | -214.53% |
| McKesson Corporation | 3.9 Billion USD | 89.017% |
| Patterson Companies, Inc. | 252.92 Million USD | -69.748% |
| Quest Diagnostics Incorporated | 1.26 Billion USD | 65.98% |
| ResMed Inc. | 1.31 Billion USD | 67.472% |
| Henry Schein, Inc. | 615 Million USD | 30.19% |
| Teladoc Health, Inc. | -248.55 Million USD | 272.733% |
| Universal Health Services, Inc. | 1.17 Billion USD | 63.473% |
| Baxter International Inc. | 390 Million USD | -10.086% |
| Becton, Dickinson and Company | 2.11 Billion USD | 79.662% |
| Intuitive Surgical, Inc. | 1.76 Billion USD | 75.7% |
| Danaher Corporation | 5.38 Billion USD | 92.021% |
| Stryker Corporation | 3.88 Billion USD | 88.957% |
| Medtronic plc | 5.14 Billion USD | 91.654% |